The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 347:1381-1382 October 24, 2002 Number 17
NextNext

Head Lice

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Roberts, R. J.
-PubMed Citation
To the Editor: In his article on head lice (May 23 issue),1 Roberts discusses several possible treatments. On the basis of in vitro studies of both sensitive and resistant head lice as well as clinical experience in the United States, topical malathion appears to be the most effective treatment. However, studies of shorter application times (10 to 30 minutes) and in children less than six years of age should be conducted.2,3,4 The formulation of malathion that is available in the United States is very effective, but this product is not available in other countries. Lindane, which is now banned in . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.